study,treatment,responders,sampleSize,rob,ind
Harrison SA 2018,Aldafermin,47,55,1,1
Harrison SA 2018,Placebo,2,27,1,1
Harrison SA 2021a,Aldafermin,34,52,1,1
Harrison SA 2021a,Placebo,7,25,1,1
Harrison SA 2022,Aldafermin,70,107,1,1
Harrison SA 2022,Placebo,11,37,1,1
Harrison SA 2021b,Efruxifermin,48,48,1,1
Harrison SA 2021b,Placebo,2,20,1,1
Harrison SA 2023a,Efruxifermin,63,73,2,1
Harrison SA 2023a,Placebo,9,42,2,1
Loomba R 2023a,Pegbelfermin,34,120,2,1
Loomba R 2023a,Placebo,2,36,2,1
Loomba R 2023b,Pegozafermin,84,131,2,1
Loomba R 2023b,Placebo,16,61,2,1
Loomba R 2023c,Pegozafermin,40,63,1,1
Loomba R 2023c,Placebo,0,18,1,1
Sanyal A 2019,Pegbelfermin,25,45,2,1
Sanyal A 2019,Placebo,6,25,2,1
Anstee QM 2023,Tropifexor,6,16,2,1
Anstee QM 2023,Cenicriviroc,2,18,2,1
Anstee QM 2023,Tropifexor + Cenicriviroc,9,39,2,1
Harrison SA 2021c,MET409,25,30,1,1
Harrison SA 2021c,Placebo,2,18,1,1
Patel K 2020,Cilofexor,28,104,2,1
Patel K 2020,Placebo,3,24,2,1
Ratziu V 2023-B,Vonafexor,25,56,1,1
Ratziu V 2023-B,Placebo,4,32,1,1
Sanyal A 2023-C,Tropifexor,47,76,2,1
Sanyal A 2023-C,Placebo,12,43,2,1
Gawrieh S 2021,Saroglitazar,15,78,3,1
Gawrieh S 2021,Placebo,2,28,3,1
Harrison SA 2023b,PXL065,31,87,1,1
Harrison SA 2023b,Placebo,5,30,1,1
Harrison SA 2019,Resmetirom,50,74,1,1
Harrison SA 2019,Placebo,10,34,1,1